LOAME
GILD icon

Lombard Odier Asset Management (Europe)’s Gilead Sciences GILD Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,000
Closed -$325K – 344
2019
Q4 		$325K Hold
5,000
– – 0.02% 277
2019
Q3 		$317K Hold
5,000
– – 0.03% 272
2019
Q2 		$338K Hold
5,000
– – 0.03% 259
2019
Q1 		$325K Buy
+5,000
New +$332K 0.03% 247

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s GILD Position: Q1 2026 in Review

Lombard Odier Asset Management (Europe) reduced its Gilead Sciences (GILD) stake by 38% in Q1 2026, selling an estimated $1.06M and leaving 12,396 shares worth $1.73M. The position accounts for 0.09% of the portfolio, ranked #169.

Lombard Odier Asset Management (Europe) first reported a position in GILD in Q4 2017 and has held it in 25 quarters since. The position peaked at $3.81M in Q4 2022. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Lombard Odier Asset Management (Europe) held 12,396 shares of Gilead Sciences worth $1.73M as of Q1 2026.
  • Lombard Odier Asset Management (Europe) sold 7,604 Gilead Sciences shares in Q1 2026, an estimated $1.06M.
  • Gilead Sciences made up 0.09% of Lombard Odier Asset Management (Europe)'s portfolio in Q1 2026, its #169 holding.
  • Lombard Odier Asset Management (Europe) first reported a position in Gilead Sciences in Q4 2017 and has held it in 25 quarters since.
  • Lombard Odier Asset Management (Europe)'s Gilead Sciences position peaked at $3.81M in Q4 2022.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q1 2026, filed 15 May 2026.